Atopic Dermatitis Latest Advances

Find the Latest Research About Atopic Dermatitis

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46991 publications

Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis Treatment.

Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis Treatment.

Journal: Journal of medicinal chemistry
Published: January 23, 2026

Dermal fibroblasts respond to interleukin-4 and 13 and promote T-cell recruitment in atopic dermatitis.

Dermal fibroblasts respond to interleukin-4 and 13 and promote T-cell recruitment in atopic dermatitis.

Journal: The Journal of clinical investigation
Published: January 22, 2026

Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine Inhibitor.

Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine Inhibitor.

Journal: JAMA dermatology
Published: January 21, 2026

Real-world effectiveness and safety of lebrikizumab maintenance dosing every 4 weeks starting at week 4 after 2 loading doses in Japanese patients with atopic dermatitis.

Real-world effectiveness and safety of lebrikizumab maintenance dosing every 4 weeks starting at week 4 after 2 loading doses in Japanese patients with atopic dermatitis.

Journal: JAAD international
Published: January 21, 2026

Incidence and prevalence of atopic disease in second and subsequent generation immigrants from Asia in Australia: a systematic review protocol.

Incidence and prevalence of atopic disease in second and subsequent generation immigrants from Asia in Australia: a systematic review protocol.

Journal: JBI evidence synthesis
Published: January 21, 2026

All-cause and cause-specific mortality in atopic dermatitis patients: a systematic review and meta-analysis.

All-cause and cause-specific mortality in atopic dermatitis patients: a systematic review and meta-analysis.

Journal: Expert review of clinical immunology
Published: January 21, 2026

Burden of acne vulgaris, psoriasis, atopic dermatitis, and urticaria in individuals under 20 years of age in China and globally, 1990-2021: A systematic analysis with 10-year forecast.

Burden of acne vulgaris, psoriasis, atopic dermatitis, and urticaria in individuals under 20 years of age in China and globally, 1990-2021: A systematic analysis with 10-year forecast.

Journal: JAAD international
Published: January 21, 2026

Integrative multi-omics analysis reveals gut-skin axis mechanisms and novel therapeutic target GALE in atopic dermatitis.

Integrative multi-omics analysis reveals gut-skin axis mechanisms and novel therapeutic target GALE in atopic dermatitis.

Journal: mSystems
Published: January 20, 2026

Cost-utility and budget impact analysis of dupilumab and oral Janus kinase (JAK) inhibitors for treating moderate-to-severe atopic dermatitis in Taiwan.

Cost-utility and budget impact analysis of dupilumab and oral Janus kinase (JAK) inhibitors for treating moderate-to-severe atopic dermatitis in Taiwan.

Journal: Journal of medical economics
Published: January 20, 2026

Bullous eczema with hyaluronic acid deposition: A case report.

Bullous eczema with hyaluronic acid deposition: A case report.

Journal: JAAD case reports
Published: January 19, 2026

Lebrikizumab-induced psoriasis in a patient with atopic dermatitis.

Lebrikizumab-induced psoriasis in a patient with atopic dermatitis.

Journal: JAAD case reports
Published: January 16, 2026

Safety and Efficacy of ICP-332 for Moderate to Severe Atopic Dermatitis: A Phase 2 Randomized Clinical Trial.

Safety and Efficacy of ICP-332 for Moderate to Severe Atopic Dermatitis: A Phase 2 Randomized Clinical Trial.

Journal: JAMA dermatology
Published: January 14, 2026
Showing 1-12 of 46,991

Last Updated: 02/24/2026